Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
This study aimed to evaluate the symptoms of chemotherapy‐induced peripheral neuropathy (CIPN) and its impact on health‐related quality of life (HRQOL) in multiple myeloma (MM) patients. A cross‐sectional survey was conducted among MM patients at a tertiary care hospital, utilizing the European Organization for Research and Treatment of Cancer Quality‐of‐Life Questionnaire for CIPN scale (QLQ‐CIPN20) and the EORTC multiple myelo ma module (QLQ‐MY20). Descriptive statistics were used for data presentation. 26 patients participated, with 61.5% being male. The average age was 64.34±8.49 years. CIPN symptoms included tingling, numbness and difficulty in walking. HRQOL challenges encompassed bone pain, back pain, feeling ill, hair loss and concerns about health and mortality. MM patients experience CIPN symptoms, impacting their HRQOL. Incorporating CIPN assessments as patient‐reported outcomes is crucial in routine clinical practice.
How to cite this article:
Abhishek Pratap Singh, Vikas Pal, Hemant Kumar Ahirwar and Garima Uikey. Chemotherapy‐Induced Peripheral Neuropathy in Multiple Myeloma Patients.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.6.217.220
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.6.217.220